ALDH18A1 is involved in the generation of a variety of epigenetically regulated intermediates in cancer, such as α-KG100, NAD(P)+57, and SAM101, and plays an important role in metabolic reprogramming and epigenetic regulation of the effects of interconnections in cancer. Here, ALDH18A1 is linked to cancer.